Come to see tomorrow's Franzoi Maria Alice talk to further understand intriguing determinants of engagement and symptoms burden in an RPM pathway across 42 European hospitals #ASCO2024

Join me on Monday June 3, 4:30PM in S100a to hear more about our CANTO study on patterns of depressive symptoms among survivors of early-stage breast cancer. #ASCO24 Ines Vaz Luis Unicancer Gustave Roussy

Clinical Science Symposium: Do not miss Antonio Di Meglio, MD, PhD - the art and science of hope moving towards patient centricity!

Come see Antonio Di Meglio, MD, PhD unraveling the complexities of depressive symptoms and trajectories after breast cancer. Too many pts struggle with unaddressed emotional distress after cancer. Super important work to inform the implementation of patient-centric symptom management.

Encouraging response rates adding pembro to platinum based chemotherapy in advanced penile cancer. Well done to all Brazilian investigators for conducting the trial in this rare but devastating disease.

Dr Franzoi Maria Alice #ASCO24 presents on remote patient monitoring with ePROs & screening for #SDOH in routine care. The vast majority had at least 1 unfavorable SDOH ...those with actionable unfavorable SDOH had lower engagement and higher symptom burden. Interventions are needed.

Although we were able to include pts with social needs in our pathway (73% among 896 pts) our data shows that low digital literacy & low treatment understanding impacts adherence to RPM. Digital health should be designed with ALL pts and implemented for ALL pts #ASCO2024

Seeing my ex-fellows - Franzoi Maria Alice and Matteo Lambertini, MD PhD - and current fellow Luca Arecco, MD shining at ASCO #ASCO24 is so rewarding Institut Jules Bordet Instituut ULB ComRecherche ESMO - Eur. Oncology OncoAlert Belgian Society of Medical Oncology

Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… New CANTO data out! Davide Soldato Lee Jones, Unicancer FabriceAndre Antonio Di Meglio, MD, PhD Martina Pagliuca Franzoi Maria Alice Gustave Roussy Cancer Survivorship Group

Very happy that our study on socioeconomic inequalities in quality of life (QoL) for patients with early breast cancer (EBC) from the CANTO Study is finally out at Journal of Clinical Oncology. ascopubs.org/doi/10.1200/JC… 👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼 🔎Setting: • ~5900 women with EBC • Treated in multiple

Ines Vas Luiz on the need for better characterization and addesssing of emerging therapy tox. #supponc #MASCC24

Finally Ines Vaz Luis discusses how we can move survivorship care forward #MASCC24: 🧐 use data to identify those at ⬆️ risk ⏰ timely, regular assessment of concerns ✅ empower patients to self monitor and manage 💻 use digital solutions to support care 🤝 coordinate care

Complex interventions require inclusive co-design and careful exploration, preparation, implementation. At Margaret Currie we presented the development of digitally-enabled behavioural interventions: PA, meditation, yoga, CBT for fatigue, anxiety, hot flashes, fear of recurrence & more.

- Let us talk about risk! Do you assess, communicate and act on individual risk of long term toxicities of your pts since diagnosis? At Margaret Currie we presented a pathway co-designed with pts & providers to tackle this need and incorporate risk prediction algorithms in clinical care.

More on co-design and pilot testing at Margaret Currie: a webplatform to accelerate decentralized research - collection of multimodal patient-generated data, activation of communities of patients & researchers, toolkits for co-design, engagement, and equity. WeShare Ines Vaz Luis

📰 Les bénéfices de la télésurveillance en oncologie se confirment à grande échelle. Publiée dans The Lancet Regional Health – Europe mercredi 31 juillet, l’étude ✨Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across